AI model combining ultrasound and digital breast tomosynthesis improves specificity in breast cancer triage
Peer-Reviewed Publication
This month, we're turning our attention to Breast Cancer Awareness Month, a time dedicated to increasing awareness, supporting early detection, and highlighting the ongoing research shaping the future of breast cancer treatment and prevention.
Updates every hour. Last Updated: 20-Oct-2026 08:16 ET (20-Oct-2026 12:16 GMT/UTC)
Scientists at Silent Spring Institute have identified 485 chemicals used in pesticide products that could increase breast cancer risk. The list includes active ingredients as well as hundreds of so-called “inert” or inactive ingredients, which typically evade safety testing. The findings could inform policies to strengthen how pesticides are regulated in the U.S. and ensure that pesticide formulations are properly evaluated for their potential to cause breast cancer.
Jefferson researchers work on prompting women who are at risk for lung cancer to get mammograms.
Rockville, MD (21September, 2026) The AIM-HI Accelerator Fund today announces that Laura Esserman, M.D., MBA, Alfred A. de Lorimier Endowed Chair in General Surgery, Director of the University of California San Francisco (UCSF) Breast Care Center, and Professor of Surgery and Radiology at the University of California, San Francisco, is selected unanimously by the 2026 Blue Ribbon Selection Committee as the recipient of the 2026 AIM-HI Beacon Award for Women Leaders in Oncology, from a pool of outstanding global nominees.